In implantable cardiac pacemakers and neurostimulators, the device casing remains continuously immersed in body fluids containing salts, enzymes, and proteins. This often leads to the corrosion and short-circuiting of internal circuitry—triggered by the permeation of polymeric materials—ultimately causing biocompatibility failure. This phenomenon constitutes a critical bottleneck that limits both the lifespan and safety of implantable devices. Phenyl silicone, leveraging its unique mechanisms of "segmental densification" and "polar repulsion," acts as a "molecular barrier shield" against body fluid permeation, constructing a three-dimensional protective layer at the microscopic level to withstand the corrosive effects of complex biological fluids.

The core mechanism by which phenyl silicone enhances resistance to body fluid permeation lies in the "steric hindrance of its phenyl groups" and the resulting "contraction of free volume." In conventional silicone, water molecules and ions (such as Na⁺ and Cl⁻) present in body fluids can easily permeate through the interstitial spaces between methyl segments; furthermore, proteins tend to adsorb onto the surface to form a biofilm, thereby accelerating the diffusion of the surrounding medium. In phenyl silicone, however, the bulky volume of the phenyl groups acts as a "molecular plug," inserting itself between the polysiloxane main chains. This reduces the free volume fraction by 35%, effectively lowering the water molecule diffusion coefficient to the order of 10⁻¹³ cm²/s. Concurrently, the non-polar nature of the phenyl groups lowers the material's surface energy to below 22 mN/m—a value lower than the surface tension of body fluids. This forces the body fluid to bead up into spherical droplets on the surface, thereby minimizing the contact area and inhibiting both protein adsorption and enzymatic degradation reactions. As validated by tests conducted in accordance with the ASTM F2584 standard, the material exhibited a weight change rate of less than 0.5% and a volume swelling rate of less than 1% after being immersed in physiological saline at 37°C for 180 days.

Furthermore, the exceptional "cross-linking network stability" of phenyl silicone enables it to withstand hydrolysis induced by body fluids. The Si-C bonds within its molecular chains possess a high bond energy of 452 kJ/mol; moreover, the formation of p-d conjugation between the phenyl groups and the silicon atoms renders the polymer backbone highly resistant to nucleophilic attacks originating from the body fluid medium. This effectively prevents the chain scission and the formation of permeation channels that would otherwise be triggered by hydrolysis. Following accelerated aging tests (60°C, 95% RH) simulating a 10-year period, its tensile strength retention rate remained above 90%.

Ranging from the molecular-level contraction of free volume to macroscopic low-permeability performance, phenyl silicone addresses the critical challenge of body fluid permeation in implantable medical devices through a synergistic mechanism characterized by "structural compactness and polar repulsion." It serves not only as a key encapsulation material ensuring the reliable operation of long-term implantable devices *in vivo*, but also as an invisible safeguard ensuring the "long-lasting and safe" maintenance of human health.